Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael A Barry

Showing results (21-30 of 180) with videos related to

Pageof 18
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|August 6, 2010
Rescue, amplification, purification, and PEGylation of replication defective first-generation adenoviral vectorsMichael A Barry, Eric A Weaver, Sean E Hofherr
Virology|January 15, 2018
Structure-based assessment of protein-protein interactions and accessibility of protein IX in adenoviruses with implications for antigen displayNathaniel L Matteson, Michael A Barry, Vijay S Reddy
Clinics in Plastic Surgery|November 19, 2003
Bone regeneration through transplantation of genetically modified cellsJeremy S Blum, Michael A Barry, Antonios G Mikos
Human Gene Therapy|March 25, 2010
Targeting adenoviruses with factor x-single-chain antibody fusion proteinsChristopher Y Chen, Shannon M May, Michael A Barry
Journal of Immunology (Baltimore, Md. : 1950)|December 26, 2001
Generation of genome-wide CD8 T cell responses in HLA-A*0201 transgenic mice by an HIV-1 ubiquitin expression library immunization vaccineRana A K Singh, Lei Wu, Michael A Barry
Human Gene Therapy|May 27, 2005
Rad23 as a reciprocal agent for stimulating or repressing immune responsesHelen A Andersson, Marco F Passeri, Michael A Barry
FEBS Letters|January 17, 2020
Retargeting adenoviruses for therapeutic applications and vaccinesMichael A Barry, Jeffrey D Rubin, Shao-Chia Lu
Current Pharmaceutical Biotechnology|July 12, 2011
Mining the adenovirus "virome" for systemic oncolyticsMichael A Barry, Eric A Weaver, Christopher Y Chen
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 15, 2004
Avidin-based targeting and purification of a protein IX-modified, metabolically biotinylated adenoviral vectorSamuel K Campos, M Brandon Parrott, Michael A Barry
Human Gene Therapy|March 21, 2006
Increased transduction of skeletal muscle cells by fibroblast growth factor-modified adenoviral vectorsKareena M Menezes, Hoyin S Mok, Michael A Barry
Pageof 18

Showing results (21-30 of 180) with videos related to

Sort By:
Pageof 18
Methods in Molecular Biology (Clifton, N.J.)|August 6, 2010
Rescue, amplification, purification, and PEGylation of replication defective first-generation adenoviral vectorsMichael A Barry, Eric A Weaver, Sean E Hofherr
Virology|January 15, 2018
Structure-based assessment of protein-protein interactions and accessibility of protein IX in adenoviruses with implications for antigen displayNathaniel L Matteson, Michael A Barry, Vijay S Reddy
Clinics in Plastic Surgery|November 19, 2003
Bone regeneration through transplantation of genetically modified cellsJeremy S Blum, Michael A Barry, Antonios G Mikos
Human Gene Therapy|March 25, 2010
Targeting adenoviruses with factor x-single-chain antibody fusion proteinsChristopher Y Chen, Shannon M May, Michael A Barry
Journal of Immunology (Baltimore, Md. : 1950)|December 26, 2001
Generation of genome-wide CD8 T cell responses in HLA-A*0201 transgenic mice by an HIV-1 ubiquitin expression library immunization vaccineRana A K Singh, Lei Wu, Michael A Barry
Human Gene Therapy|May 27, 2005
Rad23 as a reciprocal agent for stimulating or repressing immune responsesHelen A Andersson, Marco F Passeri, Michael A Barry
FEBS Letters|January 17, 2020
Retargeting adenoviruses for therapeutic applications and vaccinesMichael A Barry, Jeffrey D Rubin, Shao-Chia Lu
Current Pharmaceutical Biotechnology|July 12, 2011
Mining the adenovirus "virome" for systemic oncolyticsMichael A Barry, Eric A Weaver, Christopher Y Chen
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 15, 2004
Avidin-based targeting and purification of a protein IX-modified, metabolically biotinylated adenoviral vectorSamuel K Campos, M Brandon Parrott, Michael A Barry
Human Gene Therapy|March 21, 2006
Increased transduction of skeletal muscle cells by fibroblast growth factor-modified adenoviral vectorsKareena M Menezes, Hoyin S Mok, Michael A Barry
Pageof 18